Pioneering Regenerative Biotechnology for Enhanced Longevity.
The Institute for Regenerative Biotechnology Life Sciences (IRBLS) leads research and application in peptide therapeutics and longevity science from Zürich, Switzerland.
The Institute for Regenerative Biotechnology Life Sciences (IRBLS) is dedicated to translating scientific discovery into tangible health outcomes. Based in Zürich, we pioneer advancements in peptide therapeutics, regenerative medicine, and longevity science.
Welcome to the Institute for Regenerative Biotechnology Life Sciences (IRBLS), a premier center in Zürich dedicated to the future of human health. We bridge the gap between groundbreaking research in peptide science and regenerative medicine and its practical application for enhanced vitality, longevity, and well-being.
Explore The Peptide Book Collection Series
Delve into the science and application of peptide therapeutics with Dr. Felix Ström’s comprehensive five-volume series. Authored by the founder of IRBLS, this collection covers foundational knowledge, clinical protocols, weight management, women’s health, and skincare—an essential resource for understanding regenerative biotechnology.
Peptide Therapeutics
Harnessing the power of peptides to develop targeted therapies for health optimization, disease prevention, and enhanced recovery. Our research explores novel peptide applications and protocols.
Regenerative Medicine
Investigating and applying cutting-edge techniques to repair, replace, or regenerate human cells, tissues, or organs to restore normal function and combat age-related decline.
Longevity Science
Dedicated to understanding the biology of aging and developing evidence-based interventions, including peptide strategies, to extend healthspan and promote lifelong vitality.
Research. Regeneration. Results.
Our Research Focus
At IRBLS, our research delves into the core mechanisms of aging and regeneration. We focus on identifying novel peptide candidates, validating therapeutic protocols, and understanding the intricate interplay between biotechnology and human physiology to unlock new pathways for health optimization.
Clinical Translation
Beyond the laboratory, IRBLS is committed to translating scientific breakthroughs into effective clinical strategies. We collaborate with healthcare professionals to develop and implement evidence-based protocols, ensuring that advancements in regenerative medicine reach those who can benefit most.
IRBLS serves as a hub for knowledge exchange, fostering collaboration among scientists, clinicians, and industry partners. Through publications, seminars, and educational programs, we disseminate cutting-edge information and contribute to the global advancement of regenerative biotechnology and life sciences.
Contact Us
info@irbls.org
Maagplatz 1
8005 Zürich
Switzerland
Links
About IRBLS
Contact Us
Careers
Patient Resources
Stay Informed on Regenerative Science
Subscribe to the IRBLS newsletter for the latest updates on peptide research, longevity breakthroughs, upcoming events, and publications from our team in Zürich.